Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	150.02	191.44	113.56	144.9	287.31	222.47
Short-Term Investments	89.18	9.95	116.04	74.92	-	-
Cash & Short-Term Investments	239.2	201.39	229.6	219.81	287.31	222.47
Cash Growth	11.40%	-12.28%	4.45%	-23.49%	29.14%	111.08%
Other Receivables	0.69	0.06	0.59	0.13	0.01	0.28
Receivables	0.69	0.06	0.59	0.13	0.01	0.28
Prepaid Expenses	9.84	11.32	10.93	6.94	6.44	3.28
Other Current Assets	3.81	2.56	2.96	2.33	0.18	-
Total Current Assets	253.61	215.34	244.07	229.22	293.93	226.03
Property, Plant & Equipment	9.26	12.43	11.43	9.08	3.79	2.51
Other Long-Term Assets	0.49	0.57	0.57	0.57	0.21	0.21
Total Assets	293.32	228.34	256.07	238.87	297.93	228.75
Accounts Payable	2.49	1.7	0.77	2.39	1.5	0.75
Accrued Expenses	12.87	10.9	12.88	12.71	8.41	3.3
Current Portion of Leases	2.3	2.06	2.36	1.51	1.07	-
Current Unearned Revenue	31.61	15.31	14.88	-	-	-
Other Current Liabilities	0.6	0.86	0.51	0.54	0.46	0.05
Total Current Liabilities	49.87	30.82	31.39	17.14	11.43	4.1
Long-Term Leases	3.01	4.77	2.72	3.53	0.08	-
Long-Term Unearned Revenue	8.29	33.07	36.86	-	-	-
Other Long-Term Liabilities	0.04	0.11	0.25	0.42	0.34	0.22
Total Liabilities	61.21	68.78	71.22	21.09	11.85	4.32
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	712.29	561.43	483.17	414.02	396.35	282.46
Retained Earnings	-480.35	-401.85	-297.15	-196.08	-110.28	-58.04
Comprehensive Income & Other	0.17	-0.02	-1.18	-0.17	-	-
Total Common Equity	232.11	159.57	184.85	217.78	286.08	224.43
Shareholders' Equity	232.11	159.57	184.85	217.78	286.08	224.43
Total Liabilities & Equity	293.32	228.34	256.07	238.87	297.93	228.75
Total Debt	5.31	6.84	5.08	5.04	1.15	-
Net Cash (Debt)	263.85	194.56	224.52	214.77	286.16	222.47
Net Cash Growth	24.81%	-13.34%	4.54%	-24.95%	28.63%	111.08%
Net Cash Per Share	5.17	4.42	5.77	5.85	8.55	12.38
Filing Date Shares Outstanding	52.97	46.3	44.15	37.36	36.66	32.94
Total Common Shares Outstanding	52.94	45.92	39.44	36.9	36.58	32.86
Working Capital	203.75	184.52	212.68	212.08	282.51	221.93
Book Value Per Share	4.38	3.47	4.69	5.90	7.82	6.83
Tangible Book Value	232.11	159.57	184.85	217.78	286.08	224.43
Tangible Book Value Per Share	4.38	3.47	4.69	5.90	7.82	6.83
Machinery	-	10.14	8.57	4.93	4.15	2.68
Construction In Progress	-	0.07	0.45	1.61	0.01	0.61
Leasehold Improvements	-	2.29	1.87	0.26	0.21	0.04

Source: S&P Capital IQ. Standard template. Financial Sources.